PAR 2.00% 24.5¢ paradigm biopharmaceuticals limited..

Ann: Paradigm Receives $7.36m R&D Tax Incentive Refund, page-19

  1. 7,419 Posts.
    lightbulb Created with Sketch. 6696
    Yeah, apologies, I think we are at crossed wires in saying the same thing, i.e. the January expenditure indicated by today's report not quite as surprising some seem to think above.

    The $6M indicated January spend from the reported balance in fact in keeping or even perhaps less (given higher initial outlay expenses reported) than the $8 - $11M (including R&D refund) qtrly spend guidance (i.e. $15.5 - 18.5M spend guidance excluding refund).

    Perhaps explaining the (relief?) rally today - PAR having blown out on previous guidance.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
-0.005(2.00%)
Mkt cap ! $85.7M
Open High Low Value Volume
25.0¢ 25.0¢ 24.5¢ $94.46K 380.3K

Buyers (Bids)

No. Vol. Price($)
5 92713 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 36964 2
View Market Depth
Last trade - 16.10pm 06/06/2024 (20 minute delay) ?
Last
24.5¢
  Change
-0.005 ( 2.00 %)
Open High Low Volume
25.0¢ 25.0¢ 24.5¢ 91419
Last updated 15.19pm 06/06/2024 ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.